Eli Lilly inks deal with Camurus for its long-acting obesity technews2025-06-04T10:42:09+00:00June 4th, 2025|Endpoints News|
Agenus to divest CDMO business to Zydus for $75M upfrontnews2025-06-03T15:27:08+00:00June 3rd, 2025|Endpoints News|
#ASCO25: BioNTech presents impressive early data for PD-L1xVEGF in mesotheliomanews2025-06-03T12:00:23+00:00June 3rd, 2025|Endpoints News|
Pyx Health buys FarmboxRx to reach more Medicaid and Medicare membersnews2025-06-03T12:00:15+00:00June 3rd, 2025|Endpoints News|
Regeneron makes $80M obesity deal with Hansohnews2025-06-02T15:11:14+00:00June 2nd, 2025|Endpoints News|
Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1Bnews2025-06-02T11:20:21+00:00June 2nd, 2025|Endpoints News|
Bristol Myers and BioNTech make $1.5B upfront deal for PD-L1xVEGF cancer drugnews2025-06-02T10:45:32+00:00June 2nd, 2025|Endpoints News|
As a challenging first half nears a close, biopharma uncertainty persistsnews2025-05-30T13:46:12+00:00May 30th, 2025|Endpoints News|
Astellas licenses Claudin18.2 ADC from China’s Evopoint Biosciencesnews2025-05-29T23:30:43+00:00May 29th, 2025|Endpoints News|
Endpoints Livestream: Is the biotech market really as bad as it seems? news2025-05-28T13:52:35+00:00May 28th, 2025|Endpoints News|
